Actionable insights straight to your inbox

Equities logo

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

There's been significant M&A in fighting cancer and rare diseases — as companies seek strategic dominance in defined areas.
Most of the economic data has been negative or revised. Although the trend is mixed there is a high probability of a sell-off.
Picking small-cap health care stocks can be a pretty iffy endeavor. With the science unclear until the results of various clinical trials, it’s extremely difficult to get a reliable
It’s been a tough year for small-cap companies thus far in 2014. The recent market pullback hit growth companies hard as investors appeared to be interested in reducing the risk profile of